ChemicalBook > CAS DataBase List > Lopinavir EP impurity K

Lopinavir EP impurity K

Product Name
Lopinavir EP impurity K
CAS No.
1623021-24-8
Chemical Name
Lopinavir EP impurity K
Synonyms
Lopinavir EP impurity K;Lopinavir Impurity 11（Lopinavir EP Impurity K）;(2R)-N-[(1S,3S,4S)-1-benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2-oxotetrahydropyrimidin-1(2H)-yl]butanamide,;1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-, (αR)-
CBNumber
CB94033588
Molecular Formula
C37H48N4O5
Formula Weight
628.81
MOL File
1623021-24-8.mol
More
Less

Lopinavir EP impurity K Property

Boiling point:
924.1±65.0 °C(Predicted)
Density 
1.163±0.06 g/cm3(Predicted)
pka
13.89±0.46(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

TRC
Product number
L469545
Product name
LopinavirD-ValineDiastereomer
Packaging
50mg
Price
$600
Updated
2021/12/16
More
Less

Lopinavir EP impurity K Chemical Properties,Usage,Production

Uses

Lopinavir D-Valine Diastereomer (Lopinavir EP Impurity K) is a metabolite of Lopinavir (L469480); a selective HIV protease inhibitor and antiviral. It is a COVID19-related research product.

Lopinavir EP impurity K Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Lopinavir EP impurity K Suppliers

China 9 India 3 United States 2 Global 14
Standardpharm Co. Ltd.
Tel
86-714-3992388
Email
overseasales1@yongstandards.com
Country
United States
ProdList
14332
Advantage
58
Cato Research Chemicals Inc.
Tel
020-81215950 4000-868-328
Email
customer@uwalab.com
Country
United States
ProdList
10404
Advantage
58

1623021-24-8, Lopinavir EP impurity KRelated Search:

Lopinavir Lopinavir EP impurity O Lopinavir EP impurity I Lopinavir EP impurity L Lopinavir EP impurity E Lopinavir EP impurity M Lopinavir EP impurity H Lopinavir EP impurity Q (2S)-N-[(2S,4R,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide Lopinavir EP impurity D Lopinavir EP impurity G Lopinavir EP impurity B (αS)-3-[2-(2,6-DiMethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-diMethylphenoxy)acetyl]aMino]-3-hydroxy-5-phenyl-1-(phenylMethyl)pentyl]tetrahydro-α-(1-Methylethyl)-2-oxo-1(2H)-pyriMidineacetaMide Lopinavir EP impurity P Lopinavir EP impurity J Lopinavir EP impurity C Lopinavir EP impurity F Lopinavir EP impurity A

  • Lopinavir EP impurity K
  • Lopinavir Impurity 11（Lopinavir EP Impurity K）
  • (2R)-N-[(1S,3S,4S)-1-benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2-oxotetrahydropyrimidin-1(2H)-yl]butanamide,
  • 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-, (αR)-
  • 1623021-24-8